Strategies for epidemiologic studies of lead in bone in occupationally exposed populations. by Landrigan, P J
Environmental Health Perspectives
Vol. 91, pp. 81-86, 1991
Strategies for Epidemiologic Studies of
Lead in Bone in Occupationally Exposed
Populations
by Phillip J. Landrigan*
Lead exposure is widespread among industrial populations in the United States. X-ray fluores-
cence (XRF) analysis of the lead content of bone offers a promising approach to acquisition of in-
dividualizeddataonchronicleadabsorptioninoccupationallyexposedpopulations. Dosimetric data
obtainedby XRFwillpermitaccurate definition ofdose-response relationships for such chronic con-
sequences of lead exposure as central and peripheral neurologic impairment, renal disease, hyper-
tension, and possibly reproductive dysfunction. Additionally, data onbonelead content obtainedby
XRF will permit validation ofmodels describing the body lead burden and will allow direct assess-
ment ofthe efficacy oftherapeutic chelation. XRF data may also permit assessment ofthe possible
role ofgenetic polymorphism ofthe enzyme delta-aminolevulinic dehydrase as adeterminant ofthe
pharmacokineticsandtoxicity oflead. Inbothcross-sectionalandprospectiveepidemiologic studies
ofbody lead burden inoccupationally exposed populations, the K-XRF instrument appears to be the
technology of choice.
Introduction
Lead is a major occupational toxin. More than 1.4
million industrial workers in the United States have
potential occupational exposure to lead (1). These pop-
ulations constitute unique groups in which to under-
take epidemiologic andtoxicologic studies. The groups
are precisely defined. Data on the duration of each
worker's employment and information on job assign-
ments canbeobtainedreliably. Data onpast exposures
to lead in air have been obtainedroutinely in the lead-
using industries inthe United Statesfor at least a dec-
ade, and periodic determinations of blood lead levels
have beenrequired since 1978 (2); these data are avail-
able for epidemiologic analysis. Finally, industrial
workers have exposures to lead which typically are
higher and more prolonged than those ofthe general
population; thus, worker populations constitute
uniquely important groupsforassessingtoxiceffectsof
leadatthe upperendofthe dose-response relationship.
Inthisreview, I summarize current knowledge ofthe
toxicity oflead in industrial populations and note the
gaps in this knowledge base. I then discuss strategies
for future research to close these gaps, with particular
emphasis on approaches that may measure chronic ex-
posure to lead through determination ofthe lead con-
tent ofbone by X-ray fluorescence (XRF) analysis.
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Sinai School ofMedicine, 1 Gustave L. Levy Place, Box 1057, New
York, NY 10029-6574.
Industrial Lead Poisoning
Lead has longbeenrecognizedto cause poisoning in
industrial workers. More than 200 years B.C., Nikand-
er, aGreekpoetandphysician, describedcoma,paraly-
sis, and colic in lead workers (3). Descriptions ofhigh-
dose industrial lead poisoning were provided also by
Ramazzini in the early 1700s (4), by Charles Turner
Thackrah inVictorianEngland(5), andby Alice Ham-
ilton intheUnitedStatesearly inthiscentury(6). The
classic clinical manifestations of industrial lead poi-
soning include colic, anemia, peripheral neuropathy,
encephalopathy, renal impairment, hypertension, and
reproductive disability.
Subclinical Toxicity
More recently, the recognition has become wide-
spreadthatinadditiontoitsclinically evidenttoxicity,
lead also causes a spectrum ofadverse effects at levels
of exposure insufficient to produce obvious signs and
symptoms. The premise underlyingthis recognition is
thatthereexists acontinuumoftoxicity, inwhich clin-
ically apparent effects have their asymptomatic, sub-
clinical counterparts. Thus, clinically obvious mani-
festationsofleadpoisoningsuchasanemia,peripheral
neuropathy, andrenalfailurelieattheupperendofthe
range of toxicity, while such covert effects as slowed
nerve conduction, impaired synthesis ofheme, and al-
tered excretion ofuric acid are their subclinical corre-
lates (7,8).R J LANDRIGAN
Hematologic Toxicity
In the red blood cells, anemia is the classic clinical
manifestation oflead toxicity. The severity and preva-
lence of this anemia are correlated directly with the
blood lead level (9). The anemia oflead is produced by
two mechanisms: impairment of heme biosynthesis
and acceleration ofredblood cell destruction. Lead-in-
ducedinhibition ofhemebiosynthesis isduefirstto in-
hibition of the cytoplasmic enzyme, delta-aminolevu-
linic acid dehydratase (ALA-D) (10,11). This effect is
dose related. It is noted initially at blood lead levels of
10 to 20 jg/dL and is virtually complete at levels of70
to 90 ,tg/dL (12).
The mitochondrial enzyme ferrochelatase is the sec-
ond enzyme inthe heme biosynthetic pathway inhibit-
edbylead. Ferrochelatase catalyzesthetransferofiron
fromferritin intoprotoporphyrintoformheme(13). In-
hibition offerrochelatase causesincreased excretion of
coproporphyrin in the urine and accumulation ofpro-
toporphyrin in the erythrocytes (EP). In adult males,
EP levelsbegin to rise above background atblood lead
levels of 25 to 30 FIg/dL (14). Close correlations have
been foundbetween blood lead and EP concentrations
(15).
Neurologic Toxicity
In the peripheral nervous system, the motor axons
are the principal target of lead. Lead-induced patho-
logic changes in these fibers include segmental de-
myelination and axonal degeneration (16). Extensor
muscle palsy with wrist drop or ankle drop is the clin-
ical manifestation ofthis toxicity.
Recentstudiesoftheperipheral nervesinpersons ex-
posedtoleadhave usedelectrophysiologic probes tode-
termine whether lead causes covert abnormalities in
function. Inthefirstofthesestudies, Seppalainenetal.
found evidence for asymptomatic slowing of motor
nerve conduction velocity in workers whose blood lead
levels had never exceeded 70 ,Lg/dL (17). Araki et al.
found similar, asymptomatic dose-related slowing of
motor nerve conduction (18). Following those studies,
Seppalainen etal. examined infurther detail the dose-
response relationship between blood lead levels and
conduction velocity(19). Theyfound slowedconduction
inthesmallmotorfibersoftheulnarnervetobethemost
sensitive peripheral index ofthe neurotoxicity oflead;
in across-sectional study, ulnarnerveconductionveloc-
ity was depressed at blood lead levels below 50 gg/dL.
Most recently, in a prospective study of new entrants
to the lead industry, Seppalainen et al. found slow-
ing of ulnar nerve conduction velocity at blood lead
levels as low as 30 to 40 ig/dL (20,21).
In the central nervous system, extensive research
hassoughttodetermine whetherleadcauses asympto-
matic impairment in function at doses insufficient to
produce clinically evident encephalopathy. In one of
the earliest ofthese studies, Hanninen et al. found a
correlation between lead exposure and diminished
neuropsychologic performance in 49 asymptomatic
workers, all ofwhomhadblood leadlevelsbelow 70Atg/
dL (22). The functions most severely impaired were
those dependent on visual intelligence and visual-mo-
tor coordination. Similar findings were reported by
Valciukas et al. (23), Arnviget al. (24), andAraki et al.
(25).Bakeretal. reportedanincreasedprevalenceoffa-
tigue and short-term memory loss in smelter workers
exposed to lead; the prevalence ofthese abnormalities
increased with blood lead levels (9).
Renal Toxicity
Chronic nephropathy, which may progress to kidney
failure, isthe classicrenal manifestation ofleadtoxici-
ty. It appears toresultfrom long-term, relatively high-
dose exposure to lead.
The cells lining the proximal tubules appear to be
the tissue in the kidney most highly sensitive to lead
(26). At blood lead levels below 25 Ag/dL, lead inhibits
the metabolic activation of vitamin D, a transforma-
tionwhichoccurs inthese cells(27). Also inthese cells,
at blood lead levels of40 to 80 jig/dL, lead induces the
formation ofdense intranuclear inclusion bodies con-
sistingoflead-proteincomplex(26). Hyperuremicgout,
apparently resulting from increased reabsorption of
uricacidbythetubularcells, isathirdmetaboliccorre-
late of lead-induced renal impairment (26).
The evolution oflead nephropathy is usually silent.
The central event appears to be the progressive de-
struction oftubular cells and their replacement by fi-
brosis (28). Clinical manifestations of impairment,
consisting ofelevations in blood urea nitrogen (BUN)
or serum creatinine, do not ordinarily become evident
until 50 to 75% ofthe nephrons have been destroyed.
Pathologically, the late stage of lead nephropathy is
characterized by interstitial fibrosis with atrophy and
dilationofthetubulesandrelativesparingoftheglom-
eruli; in this stage, intranuclear inclusions are infre-
quent (26).
Excess mortality from renal disease has been ob-
served in four epidemiologic studies of lead workers
(29-32). Ineachofthese investigations, a 2-to3-fold in-
creasehasbeennotedindeathsfromchronicnephritis.
In the study by Selevan et al., a positive association
was observed between duration of employment in a
lead smelter and mortality from nephritis (32).
Lead and Hypertension
Long-term, high-dose exposure to lead was reported
early inthiscenturytobe associatedwith anincreased
incidence of hypertension and cerebrovascular acci-
dent(33). Withthe reduction in lead exposure that has
occurredinmostindustries,theseassociations are now
noted less commonly. Several recent epidemiologic
studieshave, however,foundevidencethat leadabsorp-
tion, even at relatively low levels, is associated with
significantelevation inbloodpressure(34). Toxicologic
studies have also documented an association between
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increased lead absorption and hypertension and cere-
brovascular accident (35). These effects appear to be
mediated both through the toxic effects oflead on the
kidneys, aswell asby direct action on vascular smooth
muscle.
Reproductive Toxicity of Lead
A body ofexperimental evidence indicates that lead
at high doses is toxic to reproductive function in both
male andfemale laboratory animals(36). Also, clinical
reports, most ofthemfromthefirsthalfofthiscentury,
described reproductive toxicity in workers of both
sexes withhigh-dose exposure to lead; the incidence of
spontaneous abortion was reported in these studies to
be increased in female lead workers, as well as in the
wives of male lead workers (37,38).
In male workers heavily exposed to lead(mean blood
lead level, 74.5 ig/dL) and also in males with moder-
ately increasedleadabsorption(meanblood leadlevel,
52.8 jig/dL), decreased sperm counts and an increased
prevalence of morphologically abnormal sperm have
been reported (39). Corroboration of these findings is
provided by recent American and Italian studies,
which also observed sperm count depression at rela-
tively high blood lead levels (> 60 1ig/dL)(40,41). Fur-
ther research will be required to delineate dose-re-
sponse relationships in males for the reproductive tox-
icity of lead, particularly at lower levels of exposure.
Future Research Strategies
X-Ray Fluorescence Analysis
The use ofXRF analysis to measure lead in bone of-
fers major methodologic advances over present-day
techniques for assessment of the chronic toxicity of
lead. A major limitation on studies oflead toxicity un-
dertaken heretofore isthattheyhave beenforced to re-
ly largely on determination ofthe level oflead inblood
as a biological index of exposure to lead. The half-life
oflead in blood is 36 ± 5 days (42). The blood lead level
is therefore a good indicator ofrecent exposure and is
quite satisfactory for the assessment ofeffects ofacute
nature and relatively short duration, such as anemia
orperipheral neuropathy. The blood lead level is, how-
ever, seriously deficient as an index ofchronic lead ex-
posure. Thus, it is ofonly limited value for assessing
exposure-response relationships for such long-term
consequences ofexposure to lead as renal disease, hy-
pertension, or chronic impairment ofthe central ner-
vous system (9). For evaluation ofthe natural history
anddose-response relationships oftheseeffects, a mea-
sure of chronic lead exposure will be essential. Mea-
surement ofbone lead burden by XRF analysis offers
a noninvasive and relatively rapid approach to the in-
dividualized assessment of chronic lead exposure.
XRF analysis may be undertaken using either K or
L X-rays, and both K- and L-XRF instruments have
been developed (43,44). The K instrument has several
intrinsic methodologic advantages over the L instru-
ment for use in industrial populations (45). First, the
K-XRF instrument samples lead across the entire
transverse section ofbone, in contrast to the L instru-
ment, which obtains 90% of its signal from only the
two most superficial millimeters; ifthere is variation
in the concentration of lead across the bone between
the superficial, subperiosteal and the deeper sectors,
then the L measurement will fall victim to this varia-
tion, whereas the K will not. Additionally, the K in-
strument is robust to small inaccuracies in measure-
ment of the thickness of the overlying skin, whereas
the L instrument is exquisitely sensiti'e to any error
in measurement ofskin thickness. A third methodolo-
gic advantage of the K instrument is that it is rela-
tively resistant to movement ofthe subject during the
sampling period, whereas the L instrument is sensi-
tivetomovement; giventhatthetypical samplingtime
is approximately 15 min, this consideration is not
trivial. In defense of the L instrument, there may be
detailed modeling studies in which it will be desirable
simultaneously to examine lead content in several
bone compartments. In such circumstances, the com-
bined use ofthe K and the L instruments might offer
uniquely valuable information on the kinetics oflead
in both the superficial and deeper compartments of
compactbone. XRF instrumentation may find applica-
tion in several types of epidemiologic studies, dis-
cussed in the following section.
Cross-Sectional Epidemiologic Studies
The K-XRF instrument appears to represent the sin-
gle best tool for assessment ofthe chronic toxic effects
of lead in cross-sectional studies of industrial popula-
tions. The K instrument maybe expectedtofind appli-
cation in cross-sectional studies to define dose-re-
sponse relationships for the following toxic outcomes
induced by chronic occupational exposure to lead.
Chronic Neurologic Toxicity. Further research is
required to better delineate dose-response relation-
ships between chronic exposure to lead and impair-
ment ofthe peripheral and central nervous system. In
particular, there isneedto assesstoxic effects ofchron-
ic exposure to relatively low doses oflead and to deter-
mine whether there exist thresholds for the neurotox-
icity oflead, especially in the peripheral nervous sys-
tem(46). The issue ofsubclinicaltoxicity tothe central
nervous system is not nearly so well-defined in adults
as it is in children (47). Industrial populations com-
prise important groups in which to undertake studies
of the chronic neurotoxicity of lead because of their
long-term relatively intense exposure and because
they are carefully defined and receive periodic moni-
toring ofblood lead levels and air lead exposures.
Chronic Renal Toxicity. The most important re-
search need in the study oflead nephropathy is a reli-
able early biologic indicator ofthe kidney damage in-
duced by lead(28). Such a marker wouldpermitbetter
assessment of dose-response relationships and might
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enabledeterminationoftheproportion ofcasesofrenal
failure caused by chronic exposure to lead.
Cross-sectional epidemiologic studies in industrial
populations which couple sensitive biologic indicators
ofrenal toxicity with determination ofchronic leadex-
posure by XRF analysis of lead in bone may be ex-
pected to permit substantially better definition than
heretofore of dose-response relationships for lead ne-
phropathy. Previous attempts to define these dose-re-
sponserelationships usingthebloodleadlevel asanin-
dex of exposure have largely been unsatisfactory (9),
presumably because inthe context ofchronic exposure
theblood leadlevel does notprovide adequate informa-
tion on the cumulative dose of lead to the kidneys.
Cardiovascular Toxicity andHypertension. Fur-
ther elucidation ofthe dose-response relationship be-
tween lead and hypertension and assessment of the
clinical significance oflead-induced hypertension will
also require the use ofan integrated measure ofchron-
ic lead absorption, such as may be provided by XRF
analysis of lead in bone. In future studies of lead-in-
duced hypertension, XRF analysis, coupled with con-
tinuous monitoring ofblood pressure and state-of-the-
art techniques for assessment ofrenal physiology and
catecholamine metabolism, mayprovide exceptionally
useful data for delineating the mechanisms as well as
for elucidating dose-response relationships.
Reproductive Toxicity. In addition, the K instru-
ment may find utility in cross-sectional studies to ex-
amine therelationship between lead andreproductive
dysfunction inmale workers, although at leastthe tes-
ticular component ofthis effect appearsmainly tobe of
short duration and, therefore, may be studied more ef-
fectively by use ofthe blood lead determination (40).
Toxicity and Genetic Polymorphism. Finally the
K X-ray instrument may be useful in cross-sectional
studies to assess toxic effects oflead exposure in rela-
tiontothe genetic composition ofleadworkers. The hy-
pothesis has been advanced that genetic polymor-
phism in the enzyme ALA-D may be associated with
differential metabolism of lead and differential tox-
icity oflead storage (42). Studies in which genetic as-
sessment ofALA-D polymorphism are combined with
assessment ofthe body lead burden using the K-XRF
instrument should be extremely useful in testing this
hypothesis.
Prospective Studies
Inlongitudinal prospective studies ofpopulations ex-
posed to lead, the XRF instrument may be expected to
be extremely useful. Two groups in whom prospective
studies may be undertaken are new entrants to the
lead industry and retirees or strikers, who are no
longer exposed to lead, but who had many previous
years oflead exposure. In these groups, use ofthe XRF
technology will permit examination ofeither accumu-
lation orlossofleadovertime. Amethodologic advance
thatmightbeparticularly useful insuchstudieswould
be the simultaneous use oftwo K instruments plus an
L instrument. One K instrument would examine the
tibia andprovide information onlead in dense cortical
bone. The secondK instrumentwouldexaminethe cal-
caneus to provide information on lead in trabecular
bone (49). Third, an L X-ray instrument could be used
in such studies to examine the accumulation or loss of
lead from the subperiosteal compartment of cortical
bone.
In prospective studies of workers exposed to lead,
especially if such studies were to be undertaken in
closely monitored populations ofindustrial workers, it
might be useful to compare direct estimates of bone
lead burden as derived by XRF analysis with indirect
estimates derived from serial measurements of blood
lead levels or airborne lead exposures (50).
The toxic end points that might most fruitfully be
evaluated in prospective studies of workers using the
XRF technology include toxicityto the peripheral and
central nervous system, renal toxicity, and lead-in-
duced hypertension. In essence, it may be anticipated
that these prospective studies will build upon and fol-
lowthe cross-sectional epidemiologic studiesdiscussed
in the preceding section. The great methodologic ad-
vantage that will accrue from the conduct ofrepeated
measurements ofexposureandeffectinthesamework-
ers over time in these prospective studies is that indi-
vidual variation will largely be eliminated from the
analysis as a source of background noise. In prospec-
tive studies, each subject is compared with himself or
herselfovertime, incontrastto cross-sectional studies,
in which individuals are compared with one another.
Slight changes in function over time can therefore be
detected with great reliability in prospective studies.
Prospective Studies Combined with
Chelation Therapy
Studies oflead burden in workers undergoing thera-
peutic chelation offer yet another area in which the
XRF technology may be extremely useful (50). In such
studies, the use of three instruments simultaneously
(two K instruments and an L instrument) to assess the
movement oflead from various compartments in bone
as the result ofchelation would provide extremely im-
portant data. Additionally, it would be important in
such studies to correlate the loss oflead from various
bony compartments with possible improvements in
function ofvarious end organs, including the nervous
system, the kidneys, and the reproductive organs.
Pharmacokinetic Modeling
The XRF instrumentation will be extremely impor-
tantforrefiningexistingmodelsofthepharmacokinet-
ics oflead(49,50). One ofthe most useful models ofthe
body burden and pharmacokinetics of lead currently
extant is that developed by Bernard and refined by
Hattis (51,52). It posits the existence offive functional
compartments. Only limited experimental validation
ofthis model is, however, available at present. The use
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ofthe XRF instrumentation in prospective studies, as
well as inworkers undergoingchelation, will be extra-
ordinarily useful in providing validation and further
refinement of this and other models.
Conclusion
In summary, worker populations will be exception-
ally valuable for the assessment and further devel-
opment of the XRF technology. The three particular
advantages provided by worker populations for such
studies are a) they are closely defined, b) they have
more intense and more prolonged exposures to lead
than the general population, and c) extensive data are
available in these populations on previous air lead ex-
posures and blood lead levels.
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